ResearcherJikei University School of MedicineNo recent work listed
Akitaka Takahara
Matched on OpenAlex author ID A5065396980. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2011: 2 papers · 2012: 1 paper · 2013: none · 2014: 2 papers
Papers 5
- Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer. Co-author DOI 10.1097/cji.0000000000000020↗
- Long-term management of gemcitabine in a patient with advanced pancreatic cancer undergoing haemodialysis. Co-author DOI 10.1179/1973947813y.0000000150↗
- Immunotherapy synergizes with chemotherapy targeting pancreatic cancer. Co-author DOI 10.2217/imt.11.150↗
- Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response. Co-author DOI 10.1007/s00262-011-1033-3↗
- Current immunotherapeutic approaches in pancreatic cancer. Co-author DOI 10.1155/2011/267539↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hisao Tajiri · 5 shared papers, 2011–2014 · strength 0.14
- Paper Long-term management of gemcitabine in a patient with advanced pancreatic cancer undergoing haemodialysis. DOI 10.1179/1973947813y.0000000150↗
- Paper Immunotherapy synergizes with chemotherapy targeting pancreatic cancer. DOI 10.2217/imt.11.150↗
- Paper Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic can… DOI 10.1097/cji.0000000000000020↗
- Shigeo Koido · 5 shared papers, 2011–2014 · strength 0.14
- Paper Long-term management of gemcitabine in a patient with advanced pancreatic cancer undergoing haemodialysis. DOI 10.1179/1973947813y.0000000150↗
- Paper Immunotherapy synergizes with chemotherapy targeting pancreatic cancer. DOI 10.2217/imt.11.150↗
- Paper Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic can… DOI 10.1097/cji.0000000000000020↗
- Sadamu Homma · 4 shared papers, 2011–2014 · strength 0.10
- Paper Immunotherapy synergizes with chemotherapy targeting pancreatic cancer. DOI 10.2217/imt.11.150↗
- Paper Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic can… DOI 10.1097/cji.0000000000000020↗
- Paper Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-… DOI 10.1007/s00262-011-1033-3↗
- Shintaro Tsukinaga · 2 shared papers, 2011–2014 · strength 0.06
- Sumiyuki Nishida · 2 shared papers, 2011–2014 · strength 0.05
- Paper Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic can… DOI 10.1097/cji.0000000000000020↗
- Paper Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-… DOI 10.1007/s00262-011-1033-3↗
- Haruo Sugiyama · 2 shared papers, 2011–2014 · strength 0.05
- Paper Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic can… DOI 10.1097/cji.0000000000000020↗
- Paper Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-… DOI 10.1007/s00262-011-1033-3↗
- Mikio Kajihara · 1 shared paper, 2014 · strength 0.04
- Kazuki Takakura · 1 shared paper, 2014 · strength 0.04
- Yoichi Toyama · 1 shared paper, 2014 · strength 0.03
- Yuichiro Doki · 1 shared paper, 2014 · strength 0.03
- Hidetoshi Eguchi · 1 shared paper, 2014 · strength 0.03
- Hiroaki Nagano · 1 shared paper, 2014 · strength 0.03
- Yutaka Takeda · 1 shared paper, 2014 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.